Kovack Advisors’s Northwest Biotherapeutics NWBO Stock Holding History
Bought
Maintained
Sold
Other funds holding NWBO
GW
Kovack Advisors's NWBO Position: Q2 2022 in Review
Kovack Advisors sold out of Northwest Biotherapeutics (NWBO) in Q2 2022, closing a stake of 10,000 shares — an estimated $6K sold.
Kovack Advisors first reported a position in NWBO in Q2 2013 and held it in 5 quarters. The position peaked at $57K in Q2 2013. 14 funds tracked by Wall St. Rank hold NWBO as of Q2 2022.
- Kovack Advisors reported no remaining Northwest Biotherapeutics position as of Q2 2022 after selling out during the quarter.
- Kovack Advisors sold 10,000 Northwest Biotherapeutics shares in Q2 2022, an estimated $6K.
- Kovack Advisors first reported a position in Northwest Biotherapeutics in Q2 2013 and held it in 5 quarters.
- Kovack Advisors's Northwest Biotherapeutics position peaked at $57K in Q2 2013.
- 14 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q2 2022.
Based on Kovack Advisors's 13F filing for Q2 2022, filed 10 Aug 2022.